In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.

Ritter, Oliver; Kararigas, Georgios

Ritter, Oliver; Kararigas, Georgios.

Ritter O; Department of Cardiology, Nephrology and Pulmonology, Campus Clinic Brandenburg, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Brandenburg an der Havel, Germany.
Kararigas G; Department of Physiology, Faculty of Medicine, University of Iceland, Reykjavik.

Mayo Clin Proc ; 96(3): 821-822, 2021 03.

Article in English | MEDLINE | ID: covidwho-1002863

Subject(s)

COVID-19; Cardiovascular Diseases; Cardiovascular System; Cardiovascular Diseases/epidemiology; Female; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cardiovascular Diseases / Cardiovascular System / COVID-19 Type of study: Experimental Studies / Observational study Limits: Female / Humans Language: English Journal: Mayo Clin Proc Year: 2021 Document Type: Article Affiliation country: J.mayocp.2020.12.020

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google